Certara, Inc. (CERT) vs Rapport Therapeutics, Inc. Common Stock (RAPP)

A side-by-side comparison of Certara, Inc. and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Certara, Inc. logo
CERT
Certara, Inc.
$1.44B
$9.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Rapport Therapeutics, Inc. Common Stock logo
RAPP
Rapport Therapeutics, Inc. Common Stock
$1.49B
$31.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CERT vs RAPP

growth of $100 · dividends reinvested · last 2y
CERT -40.7% (-23.0%/yr)RAPP +54.8% (+24.4%/yr)RAPP compounded faster over this window
50100150200250Start $10020252026$59$155
CERT RAPP

CERT vs RAPP: by the numbers

  • •RAPP is the larger company ($1.49B vs $1.44B market cap).
  • •Both run net losses; CERT's is the smaller (-16.75% vs -685.80% net margin).

Metrics side by side

Valuation

MetricCERTRAPP
Forward P/E27.22N/A
P/S ratio3.5374.49
P/B ratio1.493.52
EV / EBITDA26.24N/A
FCF yield4.27%N/A

Profitability

MetricCERTRAPP
Gross margin58.33%0.00%
Operating margin1.86%0.00%
Net margin-16.75%-685.80%
ROE-7.08%-32.43%
ROIC0.59%-35.66%

Growth (annualized)

MetricCERTRAPP
Revenue CAGR (5Y)9.31%N/A
FCF CAGR (5Y)8.78%N/A
Total return CAGR (5Y)-21.31%N/A

Go deeper

Full CERT analysisFull RAPP analysisInteractive comparison tool

Dig into the metrics

Certara ROERapport Therapeutics, Inc. Common Stock ROECertara operating marginRapport Therapeutics, Inc. Common Stock operating marginCertara revenue growthRapport Therapeutics, Inc. Common Stock revenue growthCertara free cash flowRapport Therapeutics, Inc. Common Stock free cash flow

Certara & Rapport Therapeutics, Inc. Common Stock appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.